Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis

Rheumatology (Oxford). 2017 Nov 1;56(11):2037-2038. doi: 10.1093/rheumatology/kex310.

Authors

Kentaro Noda¹, Taro Ukichi¹, Kazuhiro Furuya¹, Ken Yoshida¹, Isamu Kingetsu¹, Toshikazu Tanaka², Daitaro Kurosaka¹

Affiliations

¹ Division of Rheumatology.
² Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.

PMID: 28977571
DOI: 10.1093/rheumatology/kex310

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Cardiomyopathy, Hypertrophic / chemically induced*
Dermatomyositis / drug therapy*
Female
Humans
Immunosuppressive Agents / adverse effects*
Middle Aged
Tacrolimus / adverse effects*

Substances

Immunosuppressive Agents
Tacrolimus